Senior insider sale
President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$447.8K
447.78K shares
What this filing means
FRANCIS RICHARD D plans to sell 447.78K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $447.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001973379-26-000038
Officer· President and CEO
Since Mar 2026
447.78K
Shares to sell
$447.8K
Approx. market value
781.77K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
RESTRICTED SHARE UNIT AWARD
COMPENSATION
2/15/2023
161.66KPERFORMANCE SHARE UNIT AWARD
COMPENSATION
2/15/2023
620.11KTotal acquired781.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/15/2023 | RESTRICTED SHARE UNIT AWARD COMPENSATION | 161.66K | — |
2/15/2023 | PERFORMANCE SHARE UNIT AWARD COMPENSATION | 620.11K | — |
| Total | 781.77K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
447.78K
Market value
$447.8K
2/17/2026
Total
Units
447.78K
Value
$447.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 447.78K | $447.8K | NYSE | Planned |
| Total | 447.78K | $447.8K | ||